(Q35139139)

6 August 2017

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles (English)

1 reference

6 August 2017

1 reference

Hantz O

1

1 reference

6 August 2017

Borel C

2

1 reference

6 August 2017

Trabaud C

3

1 reference

6 August 2017

Zoulim F

4

1 reference

6 August 2017

Dessolin J

5

1 reference

6 August 2017

Camplo M

6

1 reference

6 August 2017

Vlieghe P

7

1 reference

6 August 2017

Bouygues M

8

1 reference

6 August 2017

Trepo C

9

1 reference

6 August 2017

Kraus JL

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

41

1 reference

6 August 2017

11

1 reference

6 August 2017

2579-2581

1 reference

The treatment of chronic viral hepatitis

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Therapeutic basis of glycyrrhizin on chronic hepatitis B.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Inhibition of duck hepatitis B virus replication by hypericin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Suramin prevents duck hepatitis B virus infection in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Hepatitis B virus immunopathogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164169

Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS)

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9371374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9371374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9371374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.41.11.2579

0 references

PMCID

164169

1 reference

6 August 2017

1 reference